Skip to main content
Caplight Logo









Inreda Diabetic B.V.

Inreda Diabetic B.V.

Private
GoorHealthcare & Life Scienceshttps://www.inredadiabetic.nl/

Last Round

VC Round

Jul 15, 2022

Total Funding Raised

$960,000

Company Overview

Inreda Diabetic B.V. is a medical technology company that develops a bi-hormonal fully closed-loop artificial pancreas system for individuals with type 1 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

artificial pancreasclosed-loop systemdiabetes managementcontinuous glucose monitorCGMinsulin pumpautomated insulin deliveryAID systemmedical devicetype 1 diabeteshealth IoTwearable medical devicebionic pancreasglucose control algorithm

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inreda Diabetic B.V. Comparables

Compare Inreda Diabetic B.V. with similar companies based on industry and business-model similarity.

Inreda Diabetic B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ViCentra
81%
Diabeloop
80%
Beta Bionics
77%

Inreda Diabetic B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 15, 2022
GrantApr 1, 2018

Key People

Founding team and executive leadership

van Olaf Straaten

Chief Operations Officer (COO)

Executive Team

Inreda Diabetic B.V. Investors

Notable investors and investment history

Inreda Diabetic B.V. investors
InvestorRounds
UvA Ventures Holding BVSeed
European Regional Development FundGrant
WadinkoVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2024

    Monthly visitors grew 230% MoM, reaching 3.3K.

  • Jul 15, 2022

    Wadinko led the VC Round fundraise.

Inreda Diabetic B.V. Filings

Explore SEC and related filing metadata, where available.

Inreda Diabetic B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Inreda Diabetic B.V.'s valuation, stock price, and market status.

Is Inreda Diabetic B.V. a public or private company?

Inreda Diabetic B.V. is a private company.

What is the current stock price of Inreda Diabetic B.V.?

Inreda Diabetic B.V. is a private company with no public stock price. No recent secondary market data is available.

How much is Inreda Diabetic B.V. worth (valuation)?

Valuation information for Inreda Diabetic B.V. is not publicly available.

Can I buy Inreda Diabetic B.V. stock?

Inreda Diabetic B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Inreda Diabetic B.V.'s last funding round?

Inreda Diabetic B.V.'s most recent funding round was VC Round on July 15, 2022.

Who are the main investors in Inreda Diabetic B.V.?

Key investors in Inreda Diabetic B.V. include UvA Ventures Holding BV, European Regional Development Fund, Wadinko.

Will Inreda Diabetic B.V. IPO soon?

No public IPO plans have been announced for Inreda Diabetic B.V..

How can I track Inreda Diabetic B.V. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inreda Diabetic B.V.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGoor
Employee Range57
Year Founded2003
Last FundingJul 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?